Medical Xpress August 9, 2024
Davide Montebruno, University of Manitoba

Dr. Sabine Mai, Canada Research Chair in Genomic Instability and Nuclear Architecture of Cancer with the Rady Faculty of Health Sciences recently co-authored an article published in the American Journal of Hematology. The groundbreaking study shows early risk stratification of smoldering multiple myeloma, a precursor state to multiple myeloma, a deadly form of blood cancer.

Multiple remains an incurable blood , with about 4,000 people newly diagnosed in Canada per year. Patients currently survive an average of eight years after diagnosis.

Patients with smoldering multiple myeloma remain asymptomatic until the disease progresses to multiple myeloma. Currently there is no accurate prognostic tool in the clinic to identify patients who will progress to multiple myeloma.

“Without a cure, the question...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Provider, Survey / Study, Trends
Achieving Value-Based Care Through the Payvider Model
208 million Americans are classified as obese or overweight, according to new study on 132 data sources
Epic's new interoperability push, explained
How 3 Health Systems Are Scaling Hybrid & Home-Based Models
CMS finalizes new kidney transplant model: 10 things to know

Share This Article